Searched for
BARZOLVOLIMAB
Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Load More
Celldex shares slip 15% as safety concerns cloud skin drug trial winCopyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service